HCM
RMD icon

Hollencrest Capital Management’s ResMed RMD Stock Holding History

Hollencrest Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50
Closed -$13.7K – 1249
2025
Q3 		$13.7K Hold
50
– – ﹤0.01% 755
2025
Q2 		$12.9K Hold
50
– – ﹤0.01% 731
2025
Q1 		$11.2K Hold
50
– – ﹤0.01% 745
2024
Q4 		$11.4K Buy
+50
New +$12K ﹤0.01% 770

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Hollencrest Capital Management's RMD Position: Q4 2025 in Review

Hollencrest Capital Management sold out of ResMed (RMD) in Q4 2025, closing a stake of 50 shares — an estimated $13.7K sold.

Hollencrest Capital Management first reported a position in RMD in Q4 2024 and held it in 4 quarters. The position peaked at $13.7K in Q3 2025. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Hollencrest Capital Management reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Hollencrest Capital Management sold 50 ResMed shares in Q4 2025, an estimated $13.7K.
  • Hollencrest Capital Management first reported a position in ResMed in Q4 2024 and held it in 4 quarters.
  • Hollencrest Capital Management's ResMed position peaked at $13.7K in Q3 2025.
  • 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Hollencrest Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.